GenoScreen™ SARS-CoV-2 RT-qPCR Assay received 100% concordance results in the latest HKSAR Department of Health QAP (March 2021 Program)

29 March 2021 [Press release]

GenoScreen™ SARS-CoV-2 RT-qPCR Assay received 100% concordance results in the latest HKSAR Department of Health QAP (March 2021 Program)

The GenoScreen^TM SARS-CoV-2 RT-qPCR Assay again delivered a 100% concordance outcome in the HKSAR Department of Health’s latest SARS-CoV-2 Quality Assurance Program.

The samples included in this SARS-CoV-2 Quality Assurance Programme were prepared by Public Health Laboratory Services Branch, Centre for Health Protection, Department of Health, Hong Kong Special Administrative Region Government. The samples are frozen transport medium samples with or without inactivated SARS-CoV-2 (whole virus).

Please visit our product page or contact us directly if you would like to learn more.

About DiagCor

Headquartered in Hong Kong with ISO 13485 accredited Quality Management System, DiagCor has been dedicated solely to molecular diagnostics (MDx) since 2006. The global leader in flow-through hybridization technology, the company offers a range of products, solutions and services related to RNA and DNA analysis. As well as providing MDx laboratory services to Asia Pacific practitioners, DiagCor develops and manufactures MDx products and solutions, and offers MDx medical translation services and MDx consulting.

Press Contact

DiagCor Life Science

[email protected]